Live Breaking News & Updates on Waqqas Afif

Stay updated with breaking news from Waqqas afif. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UNIFI Long-Term Extension Shows Safety, Efficacy of Ustekinumab for Ulcerative Colitis Through 4 Years

Results confirmed the long-term efficacy of ustekinumab maintenance in patients with ulcerative colitis, demonstrating consistent rates of symptomatic remission and endoscopic improvement with no new safety signals. ....

Waqqas Afif , Media Center , Drug Administration , Mcgill University , Inflammatory Bowel Disease Questionnaire , Ulcerative Colitis Through , Final Results , Severely Active Ulcerative , Maintenance Ustekinumab , Ulcerative Colitis , Interleukin 23 , Il 23 , Il 12 , Inflammatory Bowel Disease , Crohn X27s Disease ,

New STELARA® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab). ....

Spring House , British Columbia , United States , Waqqas Afif , Jan Wehkamp , Colitis Organization , Division Of Experimental Medicine , Crohn Colitis Foundation , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Department Of Medicine , University Health Centre , None Of The Janssen Pharmaceutical Companies , Division Of Gastroenterology , National Institutes Of Health , Exchange Commission , Companies Of Johnson , Crohn Colitis Foundation Of America , European Crohn , Associate Professor , Experimental Medicine , Vice President , Gastroenterology Disease Area Leader , Janssen Research , Global Assessment ,